Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
After finishing at $59.23 in the prior trading day, Rhythm Pharmaceuticals Inc (NASDAQ: RYTM) closed at $59.84, up 1.03%. In other words, the price has increased by $1.03 from its previous closing price. On the day, 0.6 million shares were traded.
Ratios:
Our goal is to gain a better understanding of RYTM by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.08 and its Current Ratio is at 3.24. In the meantime, Its Debt-to-Equity ratio is 11.81 whereas as Long-Term Debt/Eq ratio is at 11.74.
On January 02, 2025, Jefferies started tracking the stock assigning a Buy rating and target price of $80.Jefferies initiated its Buy rating on January 02, 2025, with a $80 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Apr 08 ’25 when Cramer Pamela J. sold 20,760 shares for $60.14 per share. The transaction valued at 1,248,490 led to the insider holds 19,209 shares of the business.
Mazabraud Yann sold 17,750 shares of RYTM for $1,082,497 on Apr 08 ’25. The EVP, Head of International now owns 22,620 shares after completing the transaction at $60.99 per share. On Apr 08 ’25, another insider, PAMELA CRAMER, who serves as the Officer of the company, bought 20,760 shares for $54.96 each.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 29.07 while its Price-to-Book (P/B) ratio in mrq is 171.82.
Stock Price History:
Over the past 52 weeks, RYTM has reached a high of $68.58, while it has fallen to a 52-week low of $35.17. The 50-Day Moving Average of the stock is 9.19%, while the 200-Day Moving Average is calculated to be 12.10%.
Shares Statistics:
A total of 62.39M shares are outstanding, with a floating share count of 56.92M. Insiders hold about 9.97% of the company’s shares, while institutions hold 95.16% stake in the company.
